deCODE Discovers Four New Risk Factors for Prostate Cancer

Findings further increase power of DNA-based testing to identify men at substantially increased risk, and will be integrated into the deCODE ProstateCancer™ test Reykjavik, ICELAND, September 20, 2009 – deCODE genetics (Nasdaq:DCGN) today announced that a team of its...